Neurologix Gene Therapy Shows Ability To Improve "On Time" In Parkinson's

Biotech hopes to move NLX-P101 into Phase III development in 2012.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet